Advanced Search

Enzyme Replacement Therapy Stocks List

Symbol Grade Name % Change
BMRN F BioMarin Pharmaceutical Inc. 0.59
FOLD F Amicus Therapeutics, Inc. 7.20
PLX B Protalix BioTherapeutics, Inc. 6.68
RARE F Ultragenyx Pharmaceutical Inc. 1.29
View As Page of Charts
Related Industries: Biotechnology
Related Stock Lists: Biopharmaceutical Rare Diseases Biotechnology Fabry Disease Gaucher Disease Inborn Errors Of Metabolism Life Sciences Lysosomal Storage Disorder Medicine Mucopolysaccharidosis Pompe Disease Acetylcholine Achondroplasia Acid Autoimmune Disease Autoimmune Disorders Biodefense Biologics Biologics Product Biology

Related ETFs - A few ETFs which own one or more of the above listed Enzyme Replacement Therapy stocks.

Symbol Grade Name Weight
DWSH F AdvisorShares Dorsey Wright Short ETF 37.4
GNOM D Global X Genomics & Biotechnology ETF 7.18
FBT F First Trust Amex Biotech Index Fund 6.31
PBE D PowerShares Dynamic Biotech & Genome 4.86
LABD D Direxion Daily S&P Biotech Bear 3X Shares 4.76
View all Enzyme Replacement Therapy related ETFs...
Compare ETFs
  • Compare DWSH to FBT
  • Compare FBT to PBE
  • Compare PBE to LABD

    • Recent Signals

    Date Stock Signal Type
    2021-04-14 FOLD Crossed Above 20 DMA Bullish
    2021-04-14 FOLD 1,2,3 Retracement Bearish Bearish Swing Setup
    2021-04-14 FOLD Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
    2021-04-14 FOLD Pocket Pivot Bullish Swing Setup
    2021-04-14 PLX New Uptrend Bullish
    2021-04-14 PLX Upper Bollinger Band Walk Strength
    2021-04-14 PLX Pocket Pivot Bullish Swing Setup
    2021-04-14 RARE 200 DMA Resistance Bearish
    2021-04-14 RARE Shooting Star Candlestick Bearish
    2021-04-14 RARE Doji - Bearish? Reversal
    2021-04-14 RARE MACD Bullish Signal Line Cross Bullish
    2021-04-14 RARE 180 Bearish Setup Bearish Swing Setup

    Recent News for Enzyme Replacement Therapy Stocks

    Date Stock Title
    Apr 14 FOLD Fold gets back overweight rating from Cantor; says Pompe disease candidate given ‘zero credit’
    Apr 14 FOLD Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2021
    Apr 14 FOLD Why Amicus Therapeutics Stock Is Soaring Today
    Apr 14 FOLD Organigram cut on profitability concerns, Novocure downgraded despite positive news, and more in today's analyst action
    Apr 14 FOLD RIOT, MVIS, MSRT and FOLD among premarket gainers
    Apr 13 BMRN BioMarin to Host First Quarter 2021 Financial Results Conference Call and Webcast on Thursday, April 29 at 4:30pm ET
    Apr 8 FOLD Is FOLD Stock A Buy or Sell?
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Rare Diseases Biotechnology Fabry Disease Gaucher Disease Inborn Errors Of Metabolism Life Sciences Lysosomal Storage Disorder Medicine Mucopolysaccharidosis Pompe Disease Acetylcholine Achondroplasia Acid Autoimmune Disease Autoimmune Disorders Biodefense Biologics Biologics Product Biology

    Browse All Tags